Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN)

Nephrology Dialysis Transplantation

Volumn 25, Issue 10, 2010, Pages 3408-3415

  Moroni, Gabriella ^a   Gallelli, Beniamina ^a   Quaglini, Silvana ^b   Leoni, Antonio ^a   Banfi, Giovanni ^a   Passerini, Patrizia ^a   Montagnino, Giuseppe ^a   Messa, Piergiorgio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

membranous nephropathy; recurrent glomerulonephritis; renal transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ACUTE VASCULAR REJECTION; ARTICLE; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LONG TERM CARE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEINURIA; TREATMENT DURATION;

ADULT; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROTEINURIA; RECURRENCE; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77957227797     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq223     Document Type: Article

References (26)

1. Hogan SL, Muller KE, Jennette JC et al. A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis 1995; 25: 862-875
2. Ponticelli C. Membranous nephropathy. J Nephrol 2007; 20: 268-287
3. Crosson JT, Wathen RL, Raij L et al. Recurrence of membranous nephropathy after renal transplantation. Arch Int Med 1975; 135: 1101-1106
4. Petersen VP, Olsen TS, Kissmeyer-Nielsen F. Late failure of human renal transplant. An analysis of transplant disease and graft failure among 125 recipients surviving for 1 to eight years. Medicine 1975; 54: 45-69
5. Morzycka M, Croker BP, Seigler HFet al. Evaluation of recurrent glo-merulonephritis in kidney allografts. Am J Med 1982; 72: 588-598
6. Berger BE, Vincenti F, Biava C et al. De novo and recurrent membranous glomerulopathy following kidney transplantation. Transplantation 1983; 35: 315-319
7. Montagnino G, Colturi C, Banfi G et al. Membranous nephropathy in cyclosporine-treated renal transplant recipients. Transplantation 1989; 47: 725-727
8. Monga G, Mazzucco G, Basolo B. Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts. Mod Pathol 1993; 6: 249-258
9. Couchoud C., Pouteil-Noble C., Colon S. et al. Recurrence of membranous nephropathy after renal transplantation. Transplantation 1995; 59: 1275-1279
10. Cosyns JP, Couchoud C, Pouteil-Noble C et al. Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors. Clin Nephrol 1998; 50: 144-153
11. Odorico JS, Knechtle SJ, Rayhill SC. The influence of native ne-phrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 1996; 61: 228-234
12. Marcen R, Mampaso F, Teruel JL. Membranous nephropathy: recurrence after kidney transplantation. Nephrol Dial Transplant 1996; 11: 1129-1133
13. Hariharan S, Adams MB, Brennan DC. Recurrent and de novo glo-merular disease after renal transplantation: a report from Renal Allo-graft Disease Registry (RADR). Transplantation 1999; 68: 635-641
14. Briganti EM, Russ GR, McNeil JJ et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002; 347: 103-109
15. Dabade TS, Grande JP, Norby SM et al. Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study. Am J Transplant 2008; 8: 1318-1322
16. Solez K, Colvin RB, Racusen LC et al. Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephrop-athy (CAN). Am J Transplant 2007; 7: 518-526
17. Ponticelli C, Altieri P, Scolari F et al. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol 1998; 9: 444-450
18. Obermiller LE, Hay WE, Eversole M et al. Recurrent membranous glomerulonephritis in two renal transplant. Transplantation 1985; 40: 100-102
19. Amer H, Cosio FG. Significance and management of proteinuria in kidney transplant recipients. J Am Soc Nephrol 2009; 20: 2490-2492
20. Cattran DC, Appel GB, Hebert LA et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int 2001; 59: 1484-1490
21. Carneiro-Roza F, Medina-Pestana JO, Moscoso-Solorzano G et al. Initial response to immunosuppressive and renoprotective treatment in posttransplant glomerulonephritis. Transplant Proc 2006; 38: 3491-3497
22. Remuzzi G, Chiurchiu C, Abbate M et al. Rituximab for idiopathic membranous nephropathy. Lancet 2002; 360: 923-924
23. Fervenza FC, Cosio FG, Erickson SB. Rituximab treatment of idio-pathic membranous nephropathy. Kidney Int 2008; 73: 117-125
24. Weclawiak H, Ribes D, Guilbeau-Frugier C. Relapse of membranous glomerulopathy after kidney transplantation: sustained remittance induced by rituximab. Clin Nephrol 2008; 69: 373-376
25. Sirimongkolrat T, Premasathian N, Vongwiwatana A et al. Anti-CD20 monoclonal antibody (rituximab) for the treatment of membranous nephropathy after living-unrelated kidney transplantation: a case report. Transplant Proc 2008; 40: 2440-2441
26. El-Zoghby ZM, Grande JP, Fraile MG et al. Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies. Am J Transplant 2009; 9: 2800-2807